Insulin Syringes Market by Disease Type and Geography - Forecast and Analysis 2022-2026
| Published: Sep 2022 | Pages: 124 | SKU: IRTNTR74367 |
The insulin syringes market is projected to grow by USD 408.67 million with a CAGR of 4.69% during the forecast period 2021 to 2026.
This insulin syringes market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers insulin syringes market segmentation by disease type (type 2 diabetes and type 1 diabetes) and geography (North America, Europe, APAC, South America, and the Middle East and Africa). The insulin syringes market report also offers information on several market vendors, including AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc. among others.
What will the Insulin Syringes Market Size be During the Forecast Period?
Download Report Sample to Unlock the Insulin Syringes Market Size for the Forecast Period and Other Important Statistics
Insulin Syringes Market: Key Drivers, Trends, and Challenges
The rising global burden of diabetes is notably driving the insulin syringes market growth, although factors such as non-adherence to insulin regimens may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the insulin syringes market industry. The holistic analysis of the drivers will help in deducing the end goals and refining marketing strategies to gain a competitive edge.
Key Insulin Syringes Market Driver
- The rising global burden of diabetes is one of the key drivers supporting the insulin syringes market growth.
- Diabetes is a chronic disease that occurs when the body cannot use insulin effectively or when the pancreas does not produce enough insulin.
- The growing incidence of type 1 and type 2 diabetes will increase healthcare costs significantly. The average health expenditure on diabetes is approximately 9% of the total healthcare expenditure.
- As per the CDC, the average annual medical expenditure for people diagnosed with diabetes is $7,900 in the US.
- The incidence of diabetes is higher among the older population. As per the CDC statistics, around 23.1 million adults aged 65 years or older have pre-diabetes in the US.
- The prevalence of diabetes is high in European countries. Thus, the increasing incidence of diabetes is likely to drive the market with the increased adoption of insulin syringes.
Key Insulin Syringes Market Trend
- An increase in awareness programs for diabetes is one of the key insulin syringes market trends contributing to the market growth.
- Vendors are organizing exhibitions to spread awareness about diabetes as well as generate insights into product development.
- The European Foundation for the Study of Diabetes (EFSD) in Europe is a leading European funding agency for diabetes research, which aims at creating and spreading awareness of type 1 diabetes among people. There are several country-specific organizations that are striving to raise awareness of type 1 diabetes.
- Various initiatives taken to increase the awareness of diabetes management in the region will accelerate the growth of the market during the forecast period.
Key Insulin Syringes Market Challenge
- Non-adherence to insulin regimens is one of the factors hampering the insulin syringes market growth.
- Diabetes is one of the fastest-growing health problems across the globe, and its management is challenging. Several patients fail to control the disease as they do not follow the instructions provided by their healthcare providers.
- Despite insulin's potency to reduce glycated hemoglobin, insulin therapy continues to be underused in the treatment of type 1 and type 2 diabetes globally.
- Although the emergence of several new insulin analogs and insulin delivery technologies has made insulin therapy safer, more effective, and more convenient, there are still barriers to insulin adherence. Adherence to insulin regimens continues to be a major clinical problem among patients with diabetes.
- Patients have erroneous beliefs about insulin therapy, including the idea that insulin causes late-stage diabetes complications. Such factors have led to non-adherence to insulin regimens, which will further pose a challenge to the market.
This insulin syringes market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Parent Market Analysis
Technavio categorizes the global insulin syringes market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the insulin syringes market during the forecast period.
Who are the Major Insulin Syringes Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- AdvaCare Pharma
- ASP Healthcare Pty Ltd.
- Avantor Inc.
- B. Braun SE
- Becton Dickinson and Co.
- Cardinal Health Inc
- CODAN Medizinische Gerate GmbH and Co KG
- Gerresheimer AG
- Healthwarehouse.com Inc.
- Hi-Tech Medics Pvt Ltd.
- Hindustan Syringes and Medical Devices Ltd.
- LAC Healthcare Solutions
- Nipro Corp.
- Novo Nordisk AS
- Poly Medicure Ltd.
- SCHOTT AG
- Smiths Group Plc
- Terumo Corp.
- Thermo Fisher Scientific Inc.
- UltiMed Inc.
This statistical study of the insulin syringes market encompasses successful business strategies deployed by the key vendors. The insulin syringes market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Product Insights and News
- B. Braun SE - The company offers insulin syringes such as Omnican 100.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.
The vendor profiles are designed to help clients improve their market position, and the information on production and sustainability along with this report provides a detailed analysis of several leading Companies.
Insulin Syringes Market Value Chain Analysis
Our In-house experts produce extensive information on the value chain and parent market of the insulin syringes market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-end understanding of product insight and profit and also optimization and evaluation of business strategies The players across the value chain includes selective data and analysis from entire research findings as per the scope of the report.
Which are the Key Regions for Insulin Syringes Market?
For more insights on the market share of various regions, Request PDF Sample now!
43% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the insulin syringes market in North America. Market growth in this region will be faster than the growth of the market in other regions.
The increase in technological advances will facilitate the insulin syringes market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID-19 Impact and Recovery Analysis
The adoption of insulin syringe systems declined slightly due to the outbreak of COVID-19. However, by the second half of 2020, the restrictions in various countries were somewhat relaxed due to the lifting of the lockdowns. Thus, the relaxation of such restrictions will encourage people to go for health checkups and treatments, which will drive the growth of the market during the forecast period.
What are the Revenue-generating Disease Type Segments in the Insulin Syringes Market?
To gain further insights on the market contribution of various segments Request PDF Sample
The insulin syringes market share growth in the type-2 diabetes segment will be significant during the forecast period. Patients with type-2 diabetes commonly use insulin syringes to deliver insulin subcutaneously. Insulin syringes are classified into various types based on the needle length, needle gauge, and syringe capacity. Vendors are offering a wide array of syringes of different sizes for type 2 diabetes. These devices are available at affordable prices and are covered under reimbursement policies, which is driving the segment growth.
This report provides an accurate prediction of the contribution of all the segments to the growth of the insulin syringes market size and actionable market insights on the post-COVID-19 impact on each segment.
|
Insulin Syringes Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.69% |
|
Market growth 2022-2026 |
$408.67 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
4.55 |
|
Regional analysis |
North America, Europe, APAC, South America, and the Middle East and Africa |
|
Performing market contribution |
North America at 43% |
|
Key consumer countries |
US, Canada, China, Germany, and France |
|
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
|
Key companies profiled |
AdvaCare Pharma, ASP Healthcare Pty Ltd., Avantor Inc., B. Braun SE, Becton Dickinson and Co., Cardinal Health Inc, CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Healthwarehouse.com Inc., Hi-Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., LAC Healthcare Solutions, Nipro Corp., Novo Nordisk AS, Poly Medicure Ltd., SCHOTT AG, Smiths Group Plc, Terumo Corp., Thermo Fisher Scientific Inc., and UltiMed Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Insulin Syringes Market Report?
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will drive the insulin syringes market growth during the next five years
- Precise estimation of the insulin syringes market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the insulin syringes industry across North America, Europe, APAC, South America, and the Middle East and Africa
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of insulin syringes market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Disease Type
- 5.1 Market segments
- Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
- 5.2 Comparison by Disease Type
- Exhibit 26: Chart on Comparison by Disease Type
- Exhibit 27: Data Table on Comparison by Disease Type
- 5.3 Type 2 diabetes - Market size and forecast 2021-2026
- Exhibit 28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
- 5.4 Type 1 diabetes - Market size and forecast 2021-2026
- Exhibit 32: Chart on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Disease Type
- Exhibit 36: Market opportunity by Disease Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 APAC - Market size and forecast 2021-2026
- Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
- 7.6 South America - Market size and forecast 2021-2026
- Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
- 7.7 Middle East and Africa - Market size and forecast 2021-2026
- Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
- 7.8 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.9 Canada - Market size and forecast 2021-2026
- Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.10 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 France - Market size and forecast 2021-2026
- Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.13 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 B. Braun SE
- Exhibit 89: B. Braun SE - Overview
- Exhibit 90: B. Braun SE - Business segments
- Exhibit 91: B. Braun SE - Key news
- Exhibit 92: B. Braun SE - Key offerings
- Exhibit 93: B. Braun SE - Segment focus
- 10.4 Becton Dickinson and Co.
- Exhibit 94: Becton Dickinson and Co. - Overview
- Exhibit 95: Becton Dickinson and Co. - Business segments
- Exhibit 96: Becton Dickinson and Co. - Key news
- Exhibit 97: Becton Dickinson and Co. - Key offerings
- Exhibit 98: Becton Dickinson and Co. - Segment focus
- 10.5 Cardinal Health Inc
- Exhibit 99: Cardinal Health Inc - Overview
- Exhibit 100: Cardinal Health Inc - Business segments
- Exhibit 101: Cardinal Health Inc - Key news
- Exhibit 102: Cardinal Health Inc - Key offerings
- Exhibit 103: Cardinal Health Inc - Segment focus
- 10.6 CODAN Medizinische Gerate GmbH and Co KG
- Exhibit 104: CODAN Medizinische Gerate GmbH and Co KG - Overview
- Exhibit 105: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
- Exhibit 106: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
- 10.7 Gerresheimer AG
- Exhibit 107: Gerresheimer AG - Overview
- Exhibit 108: Gerresheimer AG - Business segments
- Exhibit 109: Gerresheimer AG - Key news
- Exhibit 110: Gerresheimer AG - Key offerings
- Exhibit 111: Gerresheimer AG - Segment focus
- 10.8 Hindustan Syringes and Medical Devices Ltd.
- Exhibit 112: Hindustan Syringes and Medical Devices Ltd. - Overview
- Exhibit 113: Hindustan Syringes and Medical Devices Ltd. - Product / Service
- Exhibit 114: Hindustan Syringes and Medical Devices Ltd. - Key offerings
- 10.9 Nipro Corp.
- Exhibit 115: Nipro Corp. - Overview
- Exhibit 116: Nipro Corp. - Business segments
- Exhibit 117: Nipro Corp. - Key offerings
- Exhibit 118: Nipro Corp. - Segment focus
- 10.10 SCHOTT AG
- Exhibit 119: SCHOTT AG - Overview
- Exhibit 120: SCHOTT AG - Business segments
- Exhibit 121: SCHOTT AG - Key news
- Exhibit 122: SCHOTT AG - Key offerings
- Exhibit 123: SCHOTT AG - Segment focus
- 10.11 Smiths Group Plc
- Exhibit 124: Smiths Group Plc - Overview
- Exhibit 125: Smiths Group Plc - Business segments
- Exhibit 126: Smiths Group Plc - Key news
- Exhibit 127: Smiths Group Plc - Key offerings
- Exhibit 128: Smiths Group Plc - Segment focus
- 10.12 Terumo Corp.
- Exhibit 129: Terumo Corp. - Overview
- Exhibit 130: Terumo Corp. - Business segments
- Exhibit 131: Terumo Corp. - Key news
- Exhibit 132: Terumo Corp. - Key offerings
- Exhibit 133: Terumo Corp. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 134: Inclusions checklist
- Exhibit 135: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 136: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 137: Research methodology
- Exhibit 138: Validation techniques employed for market sizing
- Exhibit 139: Information sources
- 11.5 List of abbreviations
- Exhibit 140: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
insulin syringes market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis